VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 87 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $2,430,000 | -13.4% | 105,900 | -28.1% | 0.14% | -15.2% |
| Q2 2018 | $2,806,000 | -36.5% | 147,300 | -43.8% | 0.16% | -41.8% |
| Q1 2018 | $4,418,000 | -24.2% | 262,200 | -31.6% | 0.28% | -9.6% |
| Q4 2017 | $5,827,000 | -8.1% | 383,400 | +8.2% | 0.31% | -8.2% |
| Q3 2017 | $6,343,000 | +32.6% | 354,400 | +20.8% | 0.34% | +15.3% |
| Q2 2017 | $4,782,000 | +72.1% | 293,400 | +47.8% | 0.30% | +67.6% |
| Q1 2017 | $2,779,000 | +265.7% | 198,500 | +316.1% | 0.18% | +183.9% |
| Q4 2016 | $760,000 | +25.0% | 47,700 | -12.3% | 0.06% | +8.8% |
| Q2 2016 | $608,000 | -34.3% | 54,400 | -52.7% | 0.06% | -77.0% |
| Q2 2013 | $926,000 | – | 115,000 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |